APA (7th ed.) Citation

W, C., BD, T., RJ, B., K, B., S, C., LG, E., . . . LP, T. (2022). Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology, 98(4), 154. https://doi.org/10.1212/WNL.0000000000013053

Chicago Style (17th ed.) Citation

W, Chiong, et al. "Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement." Neurology 98, no. 4 (2022): 154. https://doi.org/10.1212/WNL.0000000000013053.

MLA (9th ed.) Citation

W, Chiong, et al. "Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement." Neurology, vol. 98, no. 4, 2022, p. 154, https://doi.org/10.1212/WNL.0000000000013053.